###begin article-title 0
###xml 68 77 <span type="species:ncbi:7955">Zebrafish</span>
Identification of a Novel Retinoid by Small Molecule Screening with Zebrafish Embryos
###end article-title 0
###begin p 1
Conceived and designed the experiments: RP JY QP CS. Performed the experiments: RP JY QP CS. Analyzed the data: RP JY QP CS. Wrote the paper: CS.
###end p 1
###begin p 2
###xml 616 625 <span type="species:ncbi:7955">zebrafish</span>
###xml 946 955 <span type="species:ncbi:7955">zebrafish</span>
###xml 1085 1094 <span type="species:ncbi:7955">zebrafish</span>
Small molecules have played an important role in delineating molecular pathways involved in embryonic development and disease pathology. The need for novel small molecule modulators of biological processes has driven a number of targeted screens on large diverse libraries. However, due to the specific focus of such screens, the majority of the bioactive potential of these libraries remains unharnessed. In order to identify a higher proportion of compounds with interesting biological activities, we screened a diverse synthetic library for compounds that perturb the development of any of the multiple organs in zebrafish embryos. We identified small molecules that affect the development of a variety of structures such as heart, vasculature, brain, and body-axis. We utilized the previously known role of retinoic acid in anterior-posterior (A-P) patterning to identify the target of DTAB, a compound that caused A-P axis shortening in the zebrafish embryo. We show that DTAB is a retinoid with selective activity towards retinoic acid receptors gamma and beta. Thus, conducting zebrafish developmental screens using small molecules will not only enable the identification of compounds with diverse biological activities in a large chemical library but may also facilitate the identification of the target pathways of these biologically active molecules.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
Small molecules have proved to be powerful tools for understanding the importance of molecular pathways in development and disease. When compared to traditional genetic mutations, they have the advantage that they can be used to reversibly perturb the functions of molecules at different points of embryonic development or disease progression. Due to the concentration-dependent effects of small molecules on their targets, it is also possible to uncover phenotypes that result from partial inactivation of a pathway. Their intracellular permeability permits their use in cultured cells as well as whole organisms and makes them candidates for use in therapeutics. This has made the identification of novel small molecule modulators of important genetic networks an area of intense interest.
###end p 4
###begin p 5
###xml 140 143 140 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Ortholand1">[1]</xref>
###xml 144 147 144 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Schreiber1">[3]</xref>
###xml 221 229 221 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 395 398 395 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Mayer1">[4]</xref>
###xml 400 403 400 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Kawasumi1">[5]</xref>
###xml 1164 1172 1164 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex utero</italic>
###xml 1210 1213 1210 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-MacRae1">[6]</xref>
###xml 1004 1013 <span type="species:ncbi:7955">Zebrafish</span>
In an effort to discover novel disease modulators, a number of synthetic and natural chemical libraries have been assembled in recent years [1]-[3]. The relative simplicity of purified proteins, cultured cells, and other in vitro systems has been utilized successfully in many targeted small molecule screens, resulting in the identification of novel biological tools and therapeutic candidates [4], [5]. However, such screens interrogate a library for very specific interactions with one or a few protein targets, and hence only the small percentage of the library with one specific activity is uncovered. Thus, to explore the full potential of a diverse chemical library, a vast number of targeted screens would be essential. In contrast, the use of a complex but sensitive assay capable of identifying perturbations in thousands of potential targets simultaneously affords the possibility of uncovering a large proportion of all unknown modulators of biological pathways contained in these libraries. Zebrafish embryos make an ideal model system for in vivo small molecule screens due to their small size, optical transparency, accessibility during development ex utero, and permeability to small molecules [6]. Moreover, since embryonic development and patterning require the precise regulation of myriad different genetic networks, they are extremely sensitive to perturbations by small molecule modulators.
###end p 5
###begin p 6
###xml 122 131 <span type="species:ncbi:7955">Zebrafish</span>
A major challenge of employing phenotypic screens for identifying small molecules is delineating their molecular targets. Zebrafish embryogenesis progresses through a strictly stereotypical sequence of events choreographed by numerous signaling pathways. Perturbation of these molecular pathways leads to distinct and predictable defects in the embryos that are easily detectable and have been extensively characterized for thousands of genetic mutants (). Therefore, in many cases, the developmental defects caused by a small molecule can be linked with high resolution to a specific genetic pathway known to cause the same defect.
###end p 6
###begin p 7
Many biological pathways that govern embryonic development remain active in the adult, and the study of embryonic development has led to important insights into the role of these pathways in adult physiology and perturbations that lead to disease. Therefore, small molecule modulators of gene networks active in early development can lead to a better understanding of, and design of therapeutics for, adult diseases.
###end p 7
###begin p 8
###xml 31 40 <span type="species:ncbi:7955">zebrafish</span>
###xml 429 438 <span type="species:ncbi:7955">zebrafish</span>
###xml 786 795 <span type="species:ncbi:7955">zebrafish</span>
###xml 1051 1060 <span type="species:ncbi:7955">zebrafish</span>
###xml 1439 1448 <span type="species:ncbi:7955">zebrafish</span>
Large-scale genetic screens in zebrafish have traditionally not focused on a specific biological process but rather have searched broadly for all mutations causing visible phenotypes of any kind. These screens have identified phenotypes ranging from subtle morphological defects of the ear to cardiac arrhythmias. Subsequently, positional cloning has linked many of these phenotypes to specific gene mutations. In a similar way, zebrafish small molecule screens can interrogate a small molecule library broadly for all compounds causing visible phenotypes of any kind, and comparison to known mutant phenotypes can link specific small molecules with genes that cause similar phenotypes. We screened a small molecule library for compounds that affect patterning and organ development in zebrafish embryos. We have identified more than 100 compounds that perturb a number of different aspects of development, including body-axis, brain, heart, and vascular development. In this report, we examine one of these compounds, DTAB, as an illustration of how zebrafish phenotypes can connect small molecules with their molecular targets. DTAB was identified for its ability to cause an anterior-posterior (A-P) axis-patterning defect in the embryos. Guided by the known role of retinoic acid (RA) in A-P patterning in embryos we were able to show that DTAB exhibits a retinoid-like activity and is able to phenocopy the effects of RA treatment on zebrafish embryos. Using receptor activity assays, we demonstrate that DTAB is also able to activate the retinoic acid receptors (RARs and RXRs) with selectivity for RAR-gamma.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
Developmental screen for small molecule modulators of development
###end title 10
###begin p 11
###xml 1000 1007 1000 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g001">Fig. 1A</xref>
###xml 1100 1107 1100 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g002">Fig. 2A</xref>
###xml 569 578 <span type="species:ncbi:7955">zebrafish</span>
To identify small molecule modulators of development, 5760 compounds from a diverse synthetic chemical library (Chembridge Corporation, Diverse set E) were screened. Embryos at 1-4 hours post fertilization (hpf) were treated with the compounds and scored for obvious developmental defects in the body-axis, brain, heart, blood and vasculature at 24, 48 and 72 hours. 5540 compounds out of the 5760 tested (96%) caused no discernible phenotype at 72hpf and 45 compounds (0.8%) resulted in toxicity leading to death. 175 (3%) compounds affected normal development of the zebrafish embryos. Of these, 61 caused general developmental delay or embryos failed to hatch out of the chorion and 8 compounds caused severe disruption of multiple structures during development. The remaining 106 compounds caused phenotypes that included effects on the brain (21), heart morphology and function (43), blood and vasculature (28), gut (3), trunk and tail (20), pigment formation (3), and touch responsiveness (3) (Fig. 1A). The small molecule DTAB (IUPAC: 3-[(4,6-diphenoxy-1,3,5-triazin-2-yl)amino]benzoic acid) (Fig. 2A), caused a shortening of the body axis.
###end p 11
###begin title 12
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish small-molecule screen identifies compounds that effect development.
###end title 12
###begin p 13
###xml 46 55 <span type="species:ncbi:7955">zebrafish</span>
###xml 152 161 <span type="species:ncbi:7955">zebrafish</span>
a) 4% of the 5760 compounds screened affected zebrafish embryos. 19% of the active compounds caused lethality. 175 compounds with detectable effects on zebrafish development were identified. b-c) The small molecules used for screening had molecular weights ranging from approx. 200 daltons to 700 daltons and had log P (partition coefficient) values ranging from -10 to +15. However, the log P of the bioactive compounds were restricted to 0 to +12. b) log P values between octanol and water of all the compounds screened plotted against their molecular weights. c) log P values of all the bioactive compounds (excluding the toxic compounds) plotted against their molecular weights.
###end p 13
###begin title 14
DTAB causes anterior-posterior axis defects.
###end title 14
###begin p 15
###xml 181 190 <span type="species:ncbi:7955">Zebrafish</span>
a) Chemical structure of DTAB. b) Embryos treated with higher concentrations of DTAB showed more anterior-posterior patterning defects than those treated with lower concentrations. Zebrafish embryos were treated from 1hpf to 48hpf with different concentrations of DTAB. c) Embryos treated earlier in development, and thus for longer duration were more severely affected than those treated later. Embryos were exposed to 3 microM DTAB from different times of development to 48hpf and compared to embryos treated with the vehicle DMSO. Vehicle (DMSO) treated controls developed normally. All observations were made at 48hpf.
###end p 15
###begin title 16
Biologically active compounds have positive log P values
###end title 16
###begin p 17
###xml 559 568 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g001">Fig. 1B&#8211;C</xref>
###xml 744 751 744 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g001">Fig. 1B</xref>
###xml 932 939 932 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g001">Fig. 1C</xref>
###xml 1057 1066 <span type="species:ncbi:7955">zebrafish</span>
###xml 1107 1116 <span type="species:ncbi:7955">zebrafish</span>
Since 96% of the compounds in the library did not appear to have any effect on embryogenesis we compared the chemical properties of the active and inactive compounds to identify properties that might determine biological activity. The ability of a compound to produce a phenotype in embryos depends on its physico-chemical properties as well as its interaction with developmentally relevant molecules. In terms of their size distribution the active compounds exhibited no bias and included the full size-range of the library, from 200 daltons (Da) to 700 Da (Fig. 1B-C). The partition coefficient between octanol and water (logP) of the total library screened ranged from -10 to +15, thus containing both hydrophilic and hydrophobic compounds (Fig. 1B). However, the logP of the active compounds clustered between 0 and +15 with a marked absence of hydrophilic compounds. Within the hydrophobic range, there appeared to be no bias (Fig. 1C). Thus we speculate that hydrophilic compounds, as measured by a negative log P value are rarely active in embryonic zebrafish screens, perhaps because they penetrate zebrafish embryos less effectively.
###end p 17
###begin title 18
DTAB causes a shortening of anterior-posterior axis
###end title 18
###begin p 19
###xml 213 220 209 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g002">Fig. 2B</xref>
Treatment of embryos with DTAB (12.5 microM) at 1hpf caused a severe patterning defect resulting in embryos with almost no identifiable morphological features except scattered melanocytes across the skin surface (Fig. 2B). At 3 microM the head and tail structures were still reduced but a number of somite boundaries were apparent. At 1.5 microM there was evidence of head structures with brain folds and poorly developed eyes. There was no blood circulation and embryos exhibited pericardial edema. At the lowest concentration tested (0.75 microM) the A-P axis was extended to nearly normal lengths and anatomical structures appeared normal. Blood circulation was also normal.
###end p 19
###begin p 20
###xml 195 202 191 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g002">Fig. 2C</xref>
In order to determine if the molecular target of DTAB was functional early or late in development, the embryos were exposed to 3 microM DTAB at different developmental stages from 1hpf to 24hpf (Fig. 2C). DTAB appeared to affect development at all stages, but embryos exposed later in development exhibited weaker phenotypes, indicating a cumulative effect over time. Severity of the phenotype was also a function of the length of exposure. Embryos exposed for longer time periods showed more severe phenotypes compared to those incubated in the compound for shorter time intervals followed by removal of the compound from the water (data not shown).
###end p 20
###begin p 21
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 222 225 222 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Mullins1">[7]</xref>
###xml 261 267 261 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">krox20</italic>
###xml 338 344 338 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Krox20</italic>
###xml 439 449 435 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g003">Fig. 3 A&#8211;B</xref>
###xml 452 456 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyoD</italic>
###xml 736 745 732 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g003">Fig. 3C&#8211;D</xref>
###xml 761 767 757 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pax2.1</italic>
###xml 979 988 975 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g003">Fig. 3E&#8211;F</xref>
###xml 1064 1071 1060 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">No tail</italic>
###xml 1073 1076 1069 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ntl</italic>
###xml 1082 1091 1078 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">goosecoid</italic>
###xml 1093 1096 1089 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gsc</italic>
###xml 1243 1246 1239 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gsc</italic>
###xml 1269 1272 1265 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ntl</italic>
###xml 1292 1295 1288 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-SchulteMerker1">[8]</xref>
###xml 1297 1304 1293 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 1347 1350 1343 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ntl</italic>
###xml 1362 1365 1358 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gsc</italic>
###xml 1493 1502 1489 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g003">Fig. 3G&#8211;J</xref>
In situ hybridization for early developmental markers was performed in order to elucidate the molecular nature of the short-axis phenotype. Dorso-ventral patterning defects result in short anterior or posterior structures [7]. So, we analyzed the expression of krox20, a marker for dorsally derived hindbrain segments rhombomere 3 and 5. Krox20 expression was completely absent in embryos treated with 12.5 microM of DTAB at 4hpf onwards (Fig. 3 A-B). MyoD expression indicated that myoblasts were correctly specified in the emerging somites, however there was a severe reduction in the total number of somites compared to untreated embryos further confirming the general shortening of the anterior-posterior (A-P) axis in the embryos (Fig. 3C-D). Staining for pax2.1 in ventral structures such as pronephric ducts and dorsal structures like the midbrain-hindbrain boundary, optic stalk and otic vesicle were also absent, with only residual staining in the spinal chord neurons (Fig. 3E-F). Thus, DTAB was able to ablate both dorsal as well as ventral structures. No tail (ntl) and goosecoid (gsc) are expressed in overlapping domains in the dorsal region of the shield stage embryos. As gastrulation progresses, the two domains separate with gsc moving anteriorly and ntl moving posteriorly [8]. In situ hybridization revealed that expression of ntl as well as gsc was reduced upon exposure to DTAB, thus indicating there is a reduction in both the anterior and posterior derived structures (Fig. 3G-J).
###end p 21
###begin title 22
DTAB affects the expression of early developmental markers.
###end title 22
###begin p 23
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 105 111 105 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">krox20</italic>
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pax2a</italic>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myoD</italic>
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ntl</italic>
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gsc</italic>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">raldh2</italic>
###xml 207 214 207 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyp26a1</italic>
###xml 26 35 <span type="species:ncbi:7955">zebrafish</span>
In situ hybridizations of zebrafish embryos show that treatment with DTAB results in severe reduction of krox20, pax2a, myoD, ntl, gsc, and raldh2 staining. DTAB treated embryos exhibited an upregulation of cyp26a1 transcripts in the tail and head. Embryos were treated with 12.5 microM DTAB or DMSO control from 4hpf onwards until fixation. Embryos were fixed at 75% epiboly (G-L), 10-somite (M-N), 18-somite (C-F) and 26-somite (A,B) stages. A-B, E-F, M-N are lateral views with anterior to the left and dorsal to the top. C-D are dorsal views with anterior to the left. G-L are dorsal views with the animal pole to the top.
###end p 23
###begin title 24
DTAB activates Retinoic Acid signaling
###end title 24
###begin p 25
###xml 153 156 153 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-XavierNeto1">[9]</xref>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Begemann1">[10]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Robert1">[11]</xref>
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-DiezdelCorral1">[12]</xref>
The retinoic acid signaling pathway is known to play an important role in the anterior-posterior patterning of heart, brain, limbs, and somitic mesoderm [9][10][11][12]. Since DTAB treated embryos exhibit defects in patterning consistent with a short A-P axis we assessed if RA-signaling is perturbed by DTAB.
###end p 25
###begin p 26
###xml 97 103 97 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Raldh2</italic>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Ross1">[13]</xref>
###xml 371 377 371 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">raldh2</italic>
###xml 381 388 381 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 551 560 551 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g003">Fig. 3K&#8211;L</xref>
###xml 608 614 608 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">raldh2</italic>
###xml 712 719 712 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyp26a1</italic>
###xml 823 830 823 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyp26a1</italic>
###xml 977 986 977 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g003">Fig. 3M&#8211;N</xref>
###xml 723 732 <span type="species:ncbi:7955">zebrafish</span>
Retinoic acid is synthesized in the body by the action of Raldh2 (Retinaldehyde dehydrogenase2). Raldh2 is under the negative feedback regulation of RA. Further regulation of RA levels in the tissue is carried out by Cyp26s, RA metabolizing enzymes of the cytochrome P450 family that are induced by an increase in endogenous RA levels [13]. We analyzed the expression of raldh2 by in situ hybridization and found that during gastrulation (80% epiboly) it is expressed in the dorsal side of the embryo in the region flanking the presumptive notochord (Fig. 3K-L). Treatment with DTAB caused a decrease in the raldh2 transcript levels but the expression domains were maintained. Next we analyzed the expression of cyp26a1 in zebrafish embryos. In the absence of any treatment, 6-8 somite stage embryos express high levels of cyp26a1 in the tail bud. DTAB treated embryos exhibited an increase in the tail bud expression as well as in the anterior region of the developing brain (Fig. 3M-N). Taken together, these results suggest that there is an increase in RA signaling in DTAB treated embryos.
###end p 26
###begin p 27
###xml 96 105 96 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">all trans</italic>
###xml 302 309 302 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g004">Fig. 4A</xref>
###xml 424 427 424 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ntl</italic>
###xml 608 611 608 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ntl</italic>
###xml 646 653 646 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyp26a1</italic>
###xml 812 819 812 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyp26a1</italic>
###xml 940 949 <span type="species:ncbi:7955">zebrafish</span>
In order to understand the role of DTAB in RA signaling, we compared embryos treated with DTAB, all trans-RA, and DEAB, a small molecule inhibitor of Raldh2 activity. Embryos treated with DTAB or RA exhibited remarkably similar patterning defects leading to severely shortened anterior-posterior axis (Fig. 4A). DEAB treated embryos had a distinctive phenotype of smaller heads, curved body axis and pericardial edema. When ntl expression of DTAB and RA treated embryos were compared, they exhibited a similar loss of expression in the dorsal half of the margin. DEAB treated embryos showed no change in the ntl expression pattern. Expression of cyp26a1 was significantly upregulated in the RA, as well as DTAB treated embryos when compared to vehicle treatment. DEAB treatment caused an almost complete loss of cyp26a1 expression, which is consistent with its induction by RA signaling. In summary, DTAB and RA elicit similar responses in zebrafish embryos.
###end p 27
###begin title 28
DTAB mimics effects of RA on early development.
###end title 28
###begin p 29
###xml 169 176 169 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyp26a1</italic>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ntl</italic>
###xml 270 273 270 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ntl</italic>
###xml 350 357 350 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyp26a1</italic>
###xml 407 414 407 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyp26a1</italic>
###xml 594 601 582 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 620 623 608 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ntl</italic>
###xml 628 635 616 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyp26a1</italic>
###xml 718 725 706 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 875 881 863 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">krox20</italic>
###xml 886 890 874 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myoD</italic>
###xml 1002 1008 990 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">krox20</italic>
###xml 1013 1017 1001 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myoD</italic>
###xml 1160 1166 1136 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">krox20</italic>
###xml 1191 1195 1167 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myoD</italic>
###xml 1217 1224 1193 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
a) Treatment with DTAB, RA and DTAB+DEAB results in anterior-posterior shortened phenotype. DEAB alone caused pericardial edema, twisted body axis and downregulation of cyp26a1. DEAB treatment did not affect the ntl staining while RA and DTAB treatment led to a loss of ntl staining in the dorsal margin. DTAB, RA and DTAB+DEAB caused an increase in cyp26a1 staining but DEAB alone caused downregulation of cyp26a1. Embryos were treated with DTAB (12.5 microM), RA (1 microM), DEAB (10 microM) and DTAB+DEAB or DMSO from 1hpf to 48hpf (for the bright field photography) and to 70% epiboly (for in situ hybridization for ntl and cyp26a1). Live bright field embryos are shown anterior to the left and dorsal to the top. In situ hybridized embryos, are shown, dorsal view with the animal pole to the top. b) DTAB and RA treatment caused an expansion in the distance between the krox20 and myoD positive domains. DEAB caused a compression of the 'neck' region and led to a decrease in the distance between krox20 and myoD domains. Embryos treated with DMSO, DTAB (1.6 microM), RA (0.125 microM) and DEAB (10 microM) were fixed at 9-somite stage and hybridized for krox20 (rhombomeres 3 & 5) and myoD (somites). Following in situ hybridization the embryos were de-yolked and flattened under a coverslip for better visualization.
###end p 29
###begin p 30
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">giraffe</italic>
###xml 54 58 54 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Emoto1">[14]</xref>
###xml 91 98 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyp26a1</italic>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">krox20</italic>
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myoD</italic>
###xml 240 248 240 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neckless</italic>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Begemann2">[15]</xref>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Emoto1">[14]</xref>
###xml 450 456 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">krox20</italic>
###xml 461 465 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myoD</italic>
###xml 569 575 557 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">krox20</italic>
###xml 580 584 568 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myoD</italic>
###xml 635 642 623 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g004">Fig. 4B</xref>
###xml 770 776 758 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">krox20</italic>
###xml 781 785 769 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myoD</italic>
###xml 47 54 <span type="species:ncbi:9894">giraffe</span>
###xml 62 71 <span type="species:ncbi:7955">zebrafish</span>
###xml 835 844 <span type="species:ncbi:7955">zebrafish</span>
An increase in RA signaling, such as occurs in giraffe[14], a zebrafish mutant in the gene cyp26a1, causes an increase in the distance between the krox20 (rhombomeres 3 and 5) and the myoD (somites) staining domains while the Raldh2 mutant neckless[15] shows a decrease in the distance between rhombomere 5 and the somites [14]. We compared the effects of RA (0.125 microM), DTAB (1.6 microM) and DEAB (10 microM) treatments on the distances between krox20 and myoD domains in embryos. Consistent with previous reports, treatment with RA increased the distance between krox20 and myoD markers when compared to vehicle treated embryos (Fig. 4B) while DEAB treatment reduced the distance significantly. DTAB treatment of embryos caused an increase in the distance between krox20 and myoD staining, thus confirming that DTAB mimics RA in zebrafish embryos.
###end p 30
###begin p 31
###xml 198 205 198 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g004">Fig. 4A</xref>
###xml 222 225 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ntl</italic>
###xml 230 237 230 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyp26a1</italic>
In order to understand if DTAB elicited its effects by stimulating endogenous RA synthesis, we treated embryos with both DTAB and DEAB. Co-treated embryos resembled embryos treated with DTAB alone (Fig. 4A). Expression of ntl and cyp26a1 further confirmed that DTAB is able to induce RA signaling in embryos in the absence of Raldh2 function, thus indicating that DTAB activates RA signaling directly.
###end p 31
###begin title 32
DTAB activates RAR and RXR receptors
###end title 32
###begin p 33
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-ClagettDame1">[16]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Bastien1">[17]</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Mark1">[18]</xref>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Rees1">[19]</xref>
Retinoic acid is a lipophilic molecule that traverses the plasma membrane and binds to nuclear hormone receptors to activate target gene transcription [16]. There are two families of RA receptors known as RARs (Retinoic acid receptors) and RXRs (Rexinoid receptors) that transduce RA signals to activate transcription [17]. Differential expression and affinity of the RARs and RXRs for RA and its metabolites determine the different roles they play during development and disease [18][19].
###end p 33
###begin p 34
###xml 323 329 323 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001947-g005">Fig. 5</xref>
Since DTAB mimics effects of RA on gene expression and embryo morphology we tested DTAB for RA receptor activation. We compared the ability of RA and DTAB to activate RAR and RXR receptors in a luciferase reporter based assay in Hek293T cells. As previously reported RA was found to be a potent activator of RARs and RXRs (Fig. 5). DTAB also activated a number of RARs and RXRs, but exhibited strongest activity toward RARgamma, with significant activity toward RARbeta. DTAB caused a very modest activation of RARalpha, RXRalpha, and RXRgamma, and no significant activation of RXRbeta at concentrations tested. Thus, we conclude that DTAB is a retinoid that exhibits differential selectivity for RARgamma over all the other receptors tested.
###end p 34
###begin title 35
DTAB selectively activates RARbeta and RARgamma receptors.
###end title 35
###begin p 36
###xml 352 354 338 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 362 364 348 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
RA showed high efficiency in activating the RAR and RXR receptors. DTAB was a potent activator of RARbeta and RARgamma, but showed reduced efficiency towards RARalpha and RXRs. Hek293T cells were transfected with a luciferase reporter plasmid, a beta-gal transfection-control plasmid and an RA receptor plasmid, as indicated. Cells were treated with 10-9 M to 10-5 M concentrations of DTAB or RA at 24 hours after transfection and harvested at 48 hours post transfection for luciferase and beta-gal reporter assays. RA treated cells are shown by solid green squares and line and DTAB treated cells by solid blue triangles and line. Control cells transfected with only the luciferase and beta-gal reporter plasmids (with no RA receptor plasmid) and treated with various concentrations of RA are shown by dashed gray line and gray circles. All luciferase readings were normalized to beta-gal transfection controls. beta-gal readings remained approximately equal throughout each experimental set showing equal transfection efficiency and cell viability. X-axis denotes RA or DTAB concentration. Y-axis represents arbitrary luminescence values. All RA and DTAB activities were normalized to the respective no-treatment controls. The maximum activity was set to 100% and all values calculated thereof.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Shaw1">[20]</xref>
###xml 704 708 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Katoh1">[21]</xref>
###xml 728 732 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Katano1">[22]</xref>
###xml 878 882 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Keeler1">[23]</xref>
###xml 1133 1137 1133 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Yu1">[24]</xref>
###xml 45 54 <span type="species:ncbi:7955">zebrafish</span>
###xml 846 851 <span type="species:ncbi:9940">sheep</span>
###xml 1040 1049 <span type="species:ncbi:7955">zebrafish</span>
Forward genetic screens in flies, worms, and zebrafish have provided useful insights into the processes of patterning and embryonic development. It has become increasingly evident that the same pathways that are involved in early development are also employed in controlling adult physiology, and that misregulation of these pathways leads to disease. Thus, small molecule modulators of genetic networks involved in early development can be instrumental in understanding and designing therapeutics for adult diseases. This connection between developmental defects and discovery of novel therapies is well demonstrated by the use of cyclopamine, a hedgehog signaling antagonist, in prostate [20], gastric [21], and breast cancer [22] therapies. Cyclopamine was serendipitously discovered as a plant compound that caused cyclopia in the progeny of sheep that grazed on the plants [23]. We have previously employed the same reasoning in identifying dorsomorphin, a novel small molecule inhibitor of BMP signaling, that caused dorsalization in zebrafish embryos and shows promise in developing therapeutics for anemia of chronic disease [24].
###end p 38
###begin p 39
###xml 142 151 <span type="species:ncbi:7955">zebrafish</span>
###xml 596 605 <span type="species:ncbi:7955">zebrafish</span>
###xml 731 740 <span type="species:ncbi:7955">zebrafish</span>
###xml 788 797 <span type="species:ncbi:7955">zebrafish</span>
In order to uncover the richness of biological activities within existing chemical libraries, we performed a broad, phenotype-based screen on zebrafish embryos and identified numerous small molecules that perturbed a wide variety of different processes during development. We also observed that all the bioactive compounds identified in this screen clustered into a group with higher hydrophobicity when compared to the uniform distribution of hydrophilic and hydrophobic compounds in the whole library. We speculate that the increased hydrophobicity of compounds increases their permeability in zebrafish and that designing libraries enriched for compounds with log P values >0 could increase the 'hit-rates' of such libraries in zebrafish assays. However, it is worth noting that using zebrafish-based screens exclusively for small molecule discovery would preclude the identification of hydrophilic compounds with potentially interesting biological activities.
###end p 39
###begin p 40
###xml 264 273 <span type="species:ncbi:7955">zebrafish</span>
###xml 658 667 <span type="species:ncbi:7955">zebrafish</span>
Our broad, high-content screen identified compounds affecting development of heart, blood, vasculature, brain, and body-axis. However, identifying target pathways of small molecules that cause complex phenotypes is often a challenge. To illustrate the strength of zebrafish in target identification, we selected DTAB, which causes anterior-posterior patterning defects in embryos, as a test case. As the retinoic acid pathway is known to be involved in A-P patterning, we deduced and were able to confirm that DTAB indeed functions as a retinoid. Thus, we demonstrate that the use of previously characterized mutant phenotypes and known roles of pathways in zebrafish embryogenesis can expedite the identification of molecular targets of small molecules.
###end p 40
###begin p 41
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Schier1">[25]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Wagner1">[26]</xref>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Begemann1">[10]</xref>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Robert1">[11]</xref>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Altucci1">[27]</xref>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Altucci1">[27]</xref>
###xml 669 673 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Stadler1">[28]</xref>
###xml 789 793 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Altucci1">[27]</xref>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Njar1">[29]</xref>
###xml 1014 1018 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Asou1">[30]</xref>
###xml 1162 1166 1162 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Njar1">[29]</xref>
###xml 1168 1172 1168 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Altucci2">[31]</xref>
###xml 1174 1178 1174 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Weindl1">[32]</xref>
Retinoic acid, a product of Vitamin A (retinol) metabolism, is a very important regulator of development and differentiation. In the vertebrate embryo, RA plays a crucial role in a variety of processes such as patterning of the anterior-posterior axis [25] and development of organs including heart [26], brain [10], and limb [11]. RA and its metabolites also play a crucial role in adult physiological functions such as promoting growth and differentiation, regulating apoptosis, and maintaining homeostasis in numerous tissues [27]. These pleiotropic roles of RA have been successfully harnessed for treatment of dermatological diseases as well as cancer therapy [27][28]. RA is the first successful targeted drug for cancer and is still used to treat acute promyelocytic leukemia (APL) [27]. However, the success of RA treatment is limited by the rapidity with which RA is degraded in the body [29] and the pleiotropic effects of RA on the organism that lead to non-specific toxicity and retinoic acid syndrome [30]. Hence, discovery of retinoids with resistance to metabolism and/or restricted activity on different receptors, is an area of intense interest [29], [31], [32].
###end p 41
###begin p 42
###xml 227 231 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Rees1">[19]</xref>
###xml 480 484 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Weindl1">[32]</xref>
###xml 484 488 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Chandraratna1">[33]</xref>
Interestingly, we found that DTAB exhibits selective activity towards RARgamma and to a lesser extent towards RARbeta, compared to the broad activity of RA. RARgamma is predominantly expressed in the skin in the adult organism [19]. However, a number of other retinoid receptors are also expressed in the skin, the most abundant being RARtau. Psoriasis, a skin disease has been successfully treated with Tazarotene, a retinoid with selective activity towards RARbeta and RARgamma [32][33], indicating a specific role for RARgamma and/or RARbeta in the disease. DTAB, with its selective activation of RARbeta and RARgamma could potentially be used to develop alternative therapies for this condition.
###end p 42
###begin p 43
###xml 232 236 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Holmes1">[34]</xref>
###xml 238 242 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Langdon1">[35]</xref>
###xml 425 432 405 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 461 465 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Purton1">[36]</xref>
###xml 554 558 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Walkley1">[37]</xref>
###xml 222 231 <span type="species:ncbi:10090">nude mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
Decreased RARgamma activity has been implicated in ovarian cancer, and AHPN (CD437), an RARgamma agonist, has been shown to induce apoptosis and inhibit growth of ovarian tumor cell lines as well as transplanted tumors in nude mice [34], [35]. RARgamma is also expressed in primitive hematopoietic stem cells (HSC). Recent studies show that mice null for RARgamma have reduced numbers of HSCs and that activation of RARgamma ex vivo can induce HSC self-renewal [36]. RARgamma null mice also exhibit a non-HSC-autonomous myeloproliferative syndrome (MPS) [37]. Thus, RARgamma selective agonists may be useful in understanding and designing therapeutics for multiple diseases characterized by reduced activity of RARgamma.
###end p 43
###begin title 44
Materials and Methods
###end title 44
###begin title 45
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish maintenance
###end title 45
###begin p 46
###xml 25 34 <span type="species:ncbi:7955">zebrafish</span>
For all experiments TUAB zebrafish lines were used. Fish embryos were incubated in non-buffered E3.
###end p 46
###begin title 47
Small molecule screening
###end title 47
###begin p 48
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish embryos at approximately1hpf were arrayed in round-bottomed 96-well plates in 100 microl of E3. Each 384-well plate of Chembridge diverse set E compounds (in DMSO) was transferred to four 96-well plates. The compounds from the 96-well plates were pin-transferred (approx. 100 nl) into wells with arrayed embryos. Embryos were incubated with the compounds in a humidified box at 28degreesC and were screened for phenotypes at 24hpf, 48hpf and 72hpf under a dissecting microscope. Compounds of interest were re-tested in 24-well plates.
###end p 48
###begin title 49
Partition coefficient analysis
###end title 49
###begin p 50
Log P values of the whole tested library were calculated from values provided by Chembridge.
###end p 50
###begin title 51
Chemical compounds
###end title 51
###begin p 52
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
All-trans-retinoic acid (RA) and 4-Diethylaminobenzaldehyde DEAB) were purchased from Sigma. Stock solutions of RA (1 mM) and DEAB (10 mM) were prepared in DMSO. DTAB (5133623) was purchased from Chembridge Corporation and a 12.5 mM stock was made in DMSO.
###end p 52
###begin title 53
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
Whole-mount in situ hybridization
###end title 53
###begin p 54
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Aerne1">[38]</xref>
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">krox20</italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myoD</italic>
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Begemann2">[15]</xref>
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyp26a1</italic>
###xml 135 141 135 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">raldh2</italic>
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-DobbsMcAuliffe1">[39]</xref>
###xml 147 156 147 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">goosecoid</italic>
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gsc</italic>
###xml 167 174 167 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">no tail</italic>
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ntl</italic>
###xml 181 184 181 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-SchulteMerker1">[8]</xref>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pax2a</italic>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Thisse1">[40]</xref>
Whole-mount in situ hybridization was performed essentially as previously described [38] using probes krox20 and myoD[15], cyp26a1 and raldh2[39], goosecoid (gsc) and no tail (ntl) [8] and pax2a[40]. For each experiment with different treatments of compounds, hybridization was carried out in parallel and color development was allowed to run for the same amount of time for all samples. Digoxigenin-labelled RNA antisense probes were generated with Promega RNA transcription reagents.
###end p 54
###begin title 55
Receptor activity assays
###end title 55
###begin p 56
###xml 837 841 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001947-Mangelsdorf1">[41]</xref>
###xml 67 71 <span type="species:ncbi:9913">calf</span>
Hek293T cells were grown in DMEM containing 10% de-lipidated fetal calf serum for 24 hours and were transfected with either [pCMX-Gal-L-hRAR (with Gal4 DNA binding domain-RAR Ligand binding domain)+tk-px3-luc+tk-betagal] or [pCMX-mRXR+tk-apoA1-luc+tk-betagal]. 'No-receptor' controls were transfected with [tk-luc+tk-betagal] and treated with various concentrations of RA. 24 hours after transfection the cells were treated with RA, DTAB or left untreated. Cell lysates collected at 48 hours post-transfection were assayed for luciferase activity using the Promega luciferase reporter kit. The assay results were corrected against beta-gal activity assayed using Promega beta-gal reporter kit. All the reported results are from assays done in triplicates and repeated at least once. All the plasmids were kind gifts from Ronald M. Evans [41] or derived from those plasmids by cDNA subcloning.
###end p 56
###begin p 57
The authors thank Ronald M Evans for RA receptor activity assay plasmids and the Harvard Institute for Chemistry and Cell Biology for the use of their small molecule library collection.
###end p 57
###begin title 58
References
###end title 58
###begin article-title 59
Natural products and combinatorial chemistry: back to the future.
###end article-title 59
###begin article-title 60
Exploring the chemogenomic knowledge space with annotated chemical libraries.
###end article-title 60
###begin article-title 61
Target-oriented and diversity-oriented organic synthesis in drug discovery.
###end article-title 61
###begin article-title 62
Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen.
###end article-title 62
###begin article-title 63
Chemical genetics: elucidating biological systems with small-molecule compounds.
###end article-title 63
###begin article-title 64
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish-based small molecule discovery.
###end article-title 64
###begin article-title 65
###xml 57 66 <span type="species:ncbi:7955">zebrafish</span>
Genes establishing dorsoventral pattern formation in the zebrafish embryo: the ventral specifying genes.
###end article-title 65
###begin article-title 66
###xml 14 23 <span type="species:ncbi:7955">zebrafish</span>
Expression of zebrafish goosecoid and no tail gene products in wild-type and mutant no tail embryos.
###end article-title 66
###begin article-title 67
Retinoid signaling and cardiac anteroposterior segmentation.
###end article-title 67
###begin article-title 68
Hindbrain patterning revisited: timing and effects of retinoic acid signalling.
###end article-title 68
###begin article-title 69
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Anteroposterior patterning in the limb and digit specification: contribution of mouse genetics.
###end article-title 69
###begin article-title 70
Opposing FGF and retinoid pathways control ventral neural pattern, neuronal differentiation, and segmentation during body axis extension.
###end article-title 70
###begin article-title 71
Retinoid production and catabolism: role of diet in regulating retinol esterification and retinoic Acid oxidation.
###end article-title 71
###begin article-title 72
###xml 115 124 <span type="species:ncbi:7955">zebrafish</span>
Retinoic acid-metabolizing enzyme Cyp26a1 is essential for determining territories of hindbrain and spinal cord in zebrafish.
###end article-title 72
###begin article-title 73
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
The zebrafish neckless mutation reveals a requirement for raldh2 in mesodermal signals that pattern the hindbrain.
###end article-title 73
###begin article-title 74
The role of vitamin A in mammalian reproduction and embryonic development.
###end article-title 74
###begin article-title 75
Nuclear retinoid receptors and the transcription of retinoid-target genes.
###end article-title 75
###begin article-title 76
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis.
###end article-title 76
###begin article-title 77
The molecular biology of retinoic acid receptors: orphan from good family seeks home.
###end article-title 77
###begin article-title 78
Hedgehog signaling in the prostate.
###end article-title 78
###begin article-title 79
Hedgehog signaling pathway and gastric cancer.
###end article-title 79
###begin article-title 80
Hedgehog signaling pathway as a therapeutic target in breast cancer.
###end article-title 80
###begin article-title 81
###xml 25 46 <span type="species:ncbi:50242">Veratrum californicum</span>
Teratogenic compounds of Veratrum californicum (Durand). V. Comparison of cyclopian effects of steroidal alkaloids from the plant and structurally related compounds from other sources.
###end article-title 81
###begin article-title 82
The small molecule dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism.
###end article-title 82
###begin article-title 83
###xml 40 49 <span type="species:ncbi:7955">zebrafish</span>
Molecular genetics of axis formation in zebrafish.
###end article-title 83
###begin article-title 84
Signal transduction in early heart development (II): ventricular chamber specification, trabeculation, and heart valve formation.
###end article-title 84
###begin article-title 85
The promise of retinoids to fight against cancer.
###end article-title 85
###begin article-title 86
Therapeutic advances in cutaneous T-cell lymphoma (CTCL): from retinoids to rexinoids.
###end article-title 86
###begin article-title 87
Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases.
###end article-title 87
###begin article-title 88
2. All-trans retinoic acid in the treatment of acute promyelocytic leukemia.
###end article-title 88
###begin article-title 89
RAR and RXR modulation in cancer and metabolic disease.
###end article-title 89
###begin article-title 90
Receptor-selective retinoids for psoriasis: focus on tazarotene.
###end article-title 90
###begin article-title 91
Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
###end article-title 91
###begin article-title 92
Induction of apoptosis in ovarian carcinoma cells by AHPN/CD437 is mediated by retinoic acid receptors.
###end article-title 92
###begin article-title 93
Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo.
###end article-title 93
###begin article-title 94
RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation.
###end article-title 94
###begin article-title 95
A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency.
###end article-title 95
###begin article-title 96
Receptor tyrosine phosphatase psi is required for Delta/Notch signalling and cyclic gene expression in the presomitic mesoderm.
###end article-title 96
###begin article-title 97
###xml 77 86 <span type="species:ncbi:7955">zebrafish</span>
Feedback mechanisms regulate retinoic acid production and degradation in the zebrafish embryo.
###end article-title 97
###begin article-title 98
###xml 18 27 <span type="species:ncbi:7955">zebrafish</span>
Expression of the zebrafish genome during embryogenesis (NIH R01 RR15402).
###end article-title 98
###begin article-title 99
Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.
###end article-title 99
###begin p 100
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 100
###begin p 101
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Funding for R.T.P. from Sponsored Research Agreement from Novartis Institutes for Biomedical Research NIH - NHLBI HL079267. C.S. was supported by Postdoctoral Fellowship from Massachusetts General Hospital Fund for Medical Discovery. J.-R.J.Y. was supported by a Tosteson Fellowship from the Massachusetts Biomedical Research Corporation. None of the funders played any role in the conduct, interpretation, preparation, or approval of the manuscript.
###end p 101

